Prevalence of drug hydroxylator phenotypes in Belgium
- 1 July 1987
- journal article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 33 (4) , 439-440
- https://doi.org/10.1007/bf00637647
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Genetically determined polymorphisms in drug oxidationHepatology, 1986
- HIGH PLASMA CONCENTRATIONS OF β-RECEPTOR BLOCKING DRUGS AND DEFICIENT DEBRISOQUINE HYDROXYLATIONThe Lancet, 1982
- The genetic controlof bufuralol metabolisminmanEuropean Journal of Drug Metabolism and Pharmacokinetics, 1982
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979
- Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detectionJournal of Chromatography A, 1977